Acorah Software Products - Accounts Production 16.0.110 false true false true No description of principal activity 27 February 2024 31 October 2024 31 October 2024 15525931 Mr A S Sandhu iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15525931 2024-02-26 15525931 2024-10-31 15525931 2024-02-27 2024-10-31 15525931 frs-core:CurrentFinancialInstruments 2024-10-31 15525931 frs-bus:PrivateLimitedCompanyLtd 2024-02-27 2024-10-31 15525931 frs-bus:FilletedAccounts 2024-02-27 2024-10-31 15525931 frs-bus:Micro-entities 2024-02-27 2024-10-31 15525931 frs-bus:AuditExempt-NoAccountantsReport 2024-02-27 2024-10-31 15525931 frs-bus:Director1 2024-02-27 2024-10-31
Registered number: 15525931
BioLink Intelligence LTD
Financial Statements
For the Period 27 February 2024 to 31 October 2024
Balance Sheet
Registered number: 15525931
31 October 2024
£
Current assets 3,421
Creditors: Amounts Falling Due Within One Year (3,350 )
NET CURRENT ASSETS 71
TOTAL ASSETS LESS CURRENT LIABILITIES 71
NET ASSETS 71
CAPITAL AND RESERVES 71

Notes

1. General Information
BioLink Intelligence LTD is a private company, limited by shares, incorporated in England & Wales, registered number 15525931 . The registered office is 195 Princes Gardens, London, W3 0LT.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr A S Sandhu
Director
14 November 2024